Litcius/Paper detail

SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150

Simon Cadiou, Aleth Perdriger, S. Ardois, Jean-David Albert, Olivia Berthoud, Alain Lescoat, Pascal Guggenbuhl, Robin Francois

2021Joint Bone Spine24 citationsDOIOpen Access PDF

Topics & Concepts

Polymyalgia rheumaticaMedicineGiant cell arteritisCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyTocilizumabImmunologyVasculitisInternal medicineDiseaseRheumatoid arthritisInfectious disease (medical specialty)OutbreakVasculitis and related conditionsPeripheral Neuropathies and DisordersHeparin-Induced Thrombocytopenia and Thrombosis
SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150 | Litcius